Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 17671721)

Published in Oncol Rep on September 01, 2007

Authors

X Joann You1, Peter J Bryant, Frances Jurnak, Randall F Holcombe

Author Affiliations

1: Division of Hematology/Oncology and Chao Family Comprehensive Cancer Center, University of California, Irvine, CA 92868, USA.

Articles by these authors

Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res (2003) 2.86

Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res (2005) 1.55

Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon, DLG1, and EDD/hHYD in mammary ductal carcinoma. Cancer Res (2004) 1.51

Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy. Cancer Cell Int (2012) 1.44

Wnt signaling and colon carcinogenesis: beyond APC. J Carcinog (2011) 1.44

Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol (2004) 1.35

WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Ther (2009) 1.34

Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res (2008) 1.24

Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther (2005) 1.22

Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res (2007) 1.20

A role for adenosine deaminase in Drosophila larval development. PLoS Biol (2005) 1.18

Wnt pathway-related gene expression in inflammatory bowel disease. Dig Dis Sci (2007) 1.15

EF-Tu binding peptides identified, dissected, and affinity optimized by phage display. Chem Biol (2003) 1.15

Adenosine deaminase-related growth factors stimulate cell proliferation in Drosophila by depleting extracellular adenosine. Proc Natl Acad Sci U S A (2002) 1.09

Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res (2009) 1.05

Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Int J Oncol (2005) 1.04

A Drosophila adenosine receptor activates cAMP and calcium signaling. Insect Biochem Mol Biol (2007) 0.99

Drosophila Yurt is a new protein-4.1-like protein required for epithelial morphogenesis. Dev Genes Evol (2002) 0.94

Endoscopic ultrasound delivery of an antitumor agent to treat a case of pancreatic cancer. Nat Clin Pract Gastroenterol Hepatol (2008) 0.94

Camguk/CASK enhances Ether-á-go-go potassium current by a phosphorylation-dependent mechanism. J Neurosci (2005) 0.94

Mammalian stem cells. Pediatr Res (2006) 0.93

Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells. BMC Cell Biol (2007) 0.92

Asymmetric localization of LGN but not AGS3, two homologs of Drosophila pins, in dividing human neural progenitor cells. J Neurosci Res (2004) 0.90

Role of canonical Wnt signaling in endometrial carcinogenesis. Expert Rev Anticancer Ther (2012) 0.89

Genetic analysis of the ADGF multigene family by homologous recombination and gene conversion in Drosophila. Genetics (2003) 0.89

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. Cancer Chemother Pharmacol (2011) 0.88

Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles. Int J Mol Med (2010) 0.87

Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer. Gynecol Oncol (2012) 0.86

Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. Anticancer Drugs (2003) 0.86

Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer. Anticancer Drugs (2006) 0.85

Characterization and implications of Ca2+ binding to pectate lyase C. J Biol Chem (2003) 0.84

Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer (2007) 0.84

GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine. Vaccine (2006) 0.82

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma. Cancer Chemother Pharmacol (2011) 0.81

Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment. J Transl Med (2013) 0.81

Molecular complementarity between tetracycline and the GTPase active site of elongation factor Tu. Acta Crystallogr D Biol Crystallogr (2006) 0.79

The emerging role of adenosine deaminases in insects. Insect Biochem Mol Biol (2005) 0.79

Casein kinase I epsilon somatic mutations found in breast cancer cause overgrowth in Drosophila. Int J Dev Biol (2010) 0.79

Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors. Cancer Chemother Pharmacol (2014) 0.79

Discerning the Mauve Factor, Part 1. Altern Ther Health Med (2008) 0.78

Coculture methodologies for the study of Wnt signals. Methods Mol Biol (2008) 0.77

Solving the structure of Escherichia coli elongation factor Tu using a twinned data set. Acta Crystallogr D Biol Crystallogr (2006) 0.77

Implementation of electronic chemotherapy ordering: an opportunity to improve evidence-based oncology care. J Oncol Pract (2013) 0.76

Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy. Melanoma Res (2013) 0.76

Clinical pathways for pancreatic neuroendocrine tumors. J Gastrointest Cancer (2012) 0.76

Correction: Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy. Cancer Cell Int (2013) 0.75

Standardized cancer incidence disparities in Upper Manhattan New York City neighborhoods: the role of race/ethnicity, socioeconomic status, and known risk factors. Eur J Cancer Prev (2016) 0.75

Resolving the space-group ambiguity of crystals of tomato fruit polygalacturonase. Acta Crystallogr D Biol Crystallogr (2003) 0.75

Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe. Drugs (2007) 0.75

Does Hospital Size Affect Patient Satisfaction? Qual Manag Health Care (2017) 0.75

Developing clinical research incentives for academic oncologists. J Med Pract Manage (2015) 0.75

Limitations of ADAMTS-13 activity level in diagnosing thrombotic thrombocytopenic purpura in pregnancy. Clin Appl Thromb Hemost (2008) 0.75

Discerning the Mauve factor, Part 2. Altern Ther Health Med (2008) 0.75

SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells. Anticancer Drugs (2015) 0.75

Investigation of folding of purified recombinant GRA1 protein using web based protein disorder servers and trypsin digestion. Protein Pept Lett (2009) 0.75

In situ hybridization to evaluate the expression of Wnt and frizzled genes in mammalian tissues. Methods Mol Biol (2008) 0.75